Search research articles
Contact Us
Filters
Showing results (41-50 of 53) with videos related to
Page
of 6
Sort By:
Transplantation
|
March 1, 1991
Prophylaxis of bacterial infections with ciprofloxacin in patients undergoing bone marrow transplantation
M A Lew, K Kehoe, J Ritz, et al.
Science (New York, N.Y.)
|
April 24, 1981
Intestinal M cells: a pathway for entry of reovirus into the host
J L Wolf, D H Rubin, R Finberg, et al.
Lancet (London, England)
|
August 25, 1984
Anti-B1 monoclonal antibody and complement treatment in autologous bone-marrow transplantation for relapsed B-cell non-Hodgkin's lymphoma
L M Nadler, T Takvorian, L Botnick, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 1, 1982
Biologic activity of an idiotype-bearing suppressor T cell factor produced by a long-term T cell hybridoma
M Takaoki, M S Sy, B Whitaker, et al.
Infection and Immunity
|
November 1, 1989
Recombinant human gamma interferon enhances in vitro activation of lymphocytes isolated from patients with acquired immunodeficiency syndrome
W Heagy, T B Strom, V E Kelley, et al.
Cancer Treatment Reports
|
February 1, 1987
High-dose combination alkylating agent preparative regimen with autologous bone marrow support: the Dana-Farber Cancer Institute/Beth Israel Hospital experience
K Antman, J P Eder, A Elias, et al.
Annals of Internal Medicine
|
November 1, 1987
Ribavirin treatment of the acquired immunodeficiency syndrome (AIDS) and the acquired-immunodeficiency-syndrome-related complex (ARC). A phase 1 study shows transient clinical improvement associated with suppression of the human immunodeficiency virus and enhanced lymphocyte proliferation
C Crumpacker, W Heagy, G Bubley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1986
High-dose combination alkylating agents with autologous bone marrow support: a Phase 1 trial
W P Peters, J P Eder, W D Henner, et al.
British Journal of Haematology
|
September 21, 2000
Detection of Gov system antibodies by MAIPA reveals an immunogenicity similar to the HPA-5 alloantigens
J E Berry, C M Murphy, G A Smith, et al.
Journal of the National Cancer Institute
|
October 5, 1988
Cyclophosphamide and thiotepa with autologous bone marrow transplantation in patients with solid tumors
J P Eder, K Antman, A Elias, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 53) with videos related to
Sort By:
Page
of 6
Transplantation
|
March 1, 1991
Prophylaxis of bacterial infections with ciprofloxacin in patients undergoing bone marrow transplantation
M A Lew, K Kehoe, J Ritz, et al.
Science (New York, N.Y.)
|
April 24, 1981
Intestinal M cells: a pathway for entry of reovirus into the host
J L Wolf, D H Rubin, R Finberg, et al.
Lancet (London, England)
|
August 25, 1984
Anti-B1 monoclonal antibody and complement treatment in autologous bone-marrow transplantation for relapsed B-cell non-Hodgkin's lymphoma
L M Nadler, T Takvorian, L Botnick, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 1, 1982
Biologic activity of an idiotype-bearing suppressor T cell factor produced by a long-term T cell hybridoma
M Takaoki, M S Sy, B Whitaker, et al.
Infection and Immunity
|
November 1, 1989
Recombinant human gamma interferon enhances in vitro activation of lymphocytes isolated from patients with acquired immunodeficiency syndrome
W Heagy, T B Strom, V E Kelley, et al.
Cancer Treatment Reports
|
February 1, 1987
High-dose combination alkylating agent preparative regimen with autologous bone marrow support: the Dana-Farber Cancer Institute/Beth Israel Hospital experience
K Antman, J P Eder, A Elias, et al.
Annals of Internal Medicine
|
November 1, 1987
Ribavirin treatment of the acquired immunodeficiency syndrome (AIDS) and the acquired-immunodeficiency-syndrome-related complex (ARC). A phase 1 study shows transient clinical improvement associated with suppression of the human immunodeficiency virus and enhanced lymphocyte proliferation
C Crumpacker, W Heagy, G Bubley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1986
High-dose combination alkylating agents with autologous bone marrow support: a Phase 1 trial
W P Peters, J P Eder, W D Henner, et al.
British Journal of Haematology
|
September 21, 2000
Detection of Gov system antibodies by MAIPA reveals an immunogenicity similar to the HPA-5 alloantigens
J E Berry, C M Murphy, G A Smith, et al.
Journal of the National Cancer Institute
|
October 5, 1988
Cyclophosphamide and thiotepa with autologous bone marrow transplantation in patients with solid tumors
J P Eder, K Antman, A Elias, et al.
Page
of 6